These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2379562

  • 41. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin.
    Laugen RH, Bithell TC.
    Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379
    [Abstract] [Full Text] [Related]

  • 42. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C, Lane DA, Bode W, Henschen A.
    Eur J Biochem; 1985 Mar 15; 147(3):593-600. PubMed ID: 3979390
    [Abstract] [Full Text] [Related]

  • 43. A new dysfibrinogenemia: fibrinogen Oslo IV.
    Stormorken H, Brosstad F, Seim H.
    Thromb Haemost; 1983 Apr 28; 49(2):120-2. PubMed ID: 6868008
    [Abstract] [Full Text] [Related]

  • 44. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
    Borrell M, Vila L, Solá J, Coll I, Gómez N, González N, Rutllant ML.
    Thromb Res; 1987 Mar 01; 45(5):591-9. PubMed ID: 3109061
    [Abstract] [Full Text] [Related]

  • 45. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.
    Yoshida N, Okuma M, Hirata H, Matsuda M, Yamazumi K, Asakura S.
    Blood; 1991 Jul 01; 78(1):149-53. PubMed ID: 2070049
    [Abstract] [Full Text] [Related]

  • 46. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA, VanRoss M, Kakkar VV, Bottomley KJ, Dhir K, Holt LP, MacIver JE.
    Br J Haematol; 1980 Sep 01; 46(1):89-98. PubMed ID: 7426452
    [Abstract] [Full Text] [Related]

  • 47. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ, Orlando M, Tonini GP, Casalbore P, Sarti A, Boeri E, Giacchino R, Tentori L, Mori PG.
    Scand J Haematol; 1982 Oct 01; 29(4):287-94. PubMed ID: 7178834
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
    Amri Y, Jouini H, Becheur M, Dabboubi R, Mahjoub B, Messaoud T, Sfar MT, Casini A, de Moerloose P, Toumi NEH.
    Haemophilia; 2017 Jul 01; 23(4):e340-e347. PubMed ID: 28594476
    [Abstract] [Full Text] [Related]

  • 50. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
    Shainoff JR, Ratnoff OD, Smejkal GB, DiBello PM, Welches WR, Lill H, Mitkevich OV, Periman P.
    Thromb Res; 2001 Jan 15; 101(2):91-9. PubMed ID: 11342210
    [Abstract] [Full Text] [Related]

  • 51. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Santrůcek J, Klener P, Dyr JE.
    Thromb Res; 2007 Jan 15; 121(1):75-84. PubMed ID: 17408725
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P, Furlan M, Henschen A, Kaudewitz H, Barbui T, Hilgard P, Nenci GG, Berrettini M, Beck EA.
    Thromb Haemost; 1986 Dec 15; 56(3):401-6. PubMed ID: 3563970
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE, Schmer G.
    Thromb Res; 1985 Jan 01; 37(1):45-52. PubMed ID: 3983901
    [Abstract] [Full Text] [Related]

  • 57. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R, Suttnar J, Cápová I, Hrachovinová I, Urbánková M, Dyr JE.
    Am J Hematol; 2012 May 01; 87(5):555-7. PubMed ID: 22407772
    [Abstract] [Full Text] [Related]

  • 58. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H, Galanakis D.
    J Lab Clin Med; 1987 Dec 01; 110(6):726-33. PubMed ID: 3119749
    [Abstract] [Full Text] [Related]

  • 59. Fibrinogen Logroño. A new case of congenital dysfibrinogenemia.
    Rocha E, Lasierra J, Narvaiza MJ, Vilades E, Palacios E, Fernandez J.
    Ric Clin Lab; 1984 Dec 01; 14(4):663-72. PubMed ID: 6522973
    [Abstract] [Full Text] [Related]

  • 60. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M.
    Blood Coagul Fibrinolysis; 1994 Aug 01; 5(4):463-71. PubMed ID: 7841300
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.